Angiotensin (AT)
The angiotensin receptors are activated by the vasoconstricting peptide angiotensin II. They are important for the renin-angiotensin system (RAS) or the renin-angiotensin-aldosterone system (RAAS); a hormone system that regulates blood pressure and water (fluid) balance. Effects mediated by the AT2 receptor are suggested to include inhibition of cell growth, fetal tissue development, modulation of extracellular matrix, neuronal regeneration, apoptosis, cellular differentiation, and maybe vasodilatation and left ventricular hypertrophy[1].
[1] The Angiotensin II Type 2 Receptor Causes Constitutive Growth of Cardiomyocytes and Does Not Antagonize Angiotensin II Type 1 Receptor–Mediated Hypertrophy. A. Amore, M.J. Black, W.G. Thomas. Hypertension. 2005, 46, 1347-1354
| Axon ID | Name | Description | From price | |
|---|---|---|---|---|
| 3890 | (R)-(-)-PD123319 ditrifluoroacetate (Optically pure) | Opposite enantiomer of PD123319 ditrifluoroacetate | €140.00 | |
| 3363 | Azilsartan | Potent AT1 antagonist | €60.00 | |
| 3104 | Candesartan cilexetil | Potent and highly specific AT2 receptor antagonist | €50.00 | |
| 3550 | Fimasartan | Potent and orally active angiotensin II receptor antagonist | €70.00 | |
| 3102 | Losartan | Non-peptide, potent and orally active angiotensin II receptor antagonist | €60.00 | |
| 3105 | Olmesartan | Potent and selective AT1 antagonist | €80.00 | |
| 1276 | PD123319 ditrifluoroacetate (Optically pure S-enantiomer) | AT2 antagonist | €130.00 | |
| 3106 | Valsartan | Potent, highly selective, and orally active AT1 antagonist | €76.00 | |